IPG Photonics Net Income Jumps To $20.3 Million, But Fourth-Quarter EPS Guide Tops Out At $0.60
The laser maker's third-quarter revenue rose 15% to $287.5 million, yet its adjusted profit outlook for the fourth quarter starts well below $0.61.
IPG Photonics, which makes fiber lasers used to cut, weld, mark and clean materials, said Tuesday that third-quarter revenue rose 15% to $287.5 million and net income climbed to $20.3 million from $7.5 million a year earlier. Its fourth-quarter adjusted earnings guidance of $0.30 to $0.60 a share sits at or below the $0.61 it just earned.
Welding, chips and defense lift sales
Industrial Solutions sales grew 12% to $239.5 million, led by welding and additive manufacturing, the company said. Advanced Solutions jumped 33% to $48.0 million on semiconductor and defense sales. Foreign exchange added about 1% to total growth.
By region, sales rose 14% in Asia and 33% in North America and fell 1% in Europe. Emerging growth products made up 52% of revenue, down from 58% in the prior quarter because of product mix.
Net income was $0.47 per diluted share, against $0.18 a year earlier. Gross margin widened to 40.7% from 39.5%, helped by lower product costs and $5.0 million in net tariff refunds, partly offset by lower fixed-cost absorption. Adjusted earnings per share were $0.61, up from $0.35.
A fourth-quarter range that starts at half
For the fourth quarter, IPG expects revenue of $265 million to $295 million, a range that straddles the $287.5 million it just posted. It guided adjusted earnings per diluted share to $0.30 to $0.60, adjusted EBITDA of $33 million to $50 million, and adjusted gross margin of 37.0% to 40.0%.
The outlook assumes no contribution from the Lumibird Medical acquisition. The company also said trade policy and tariff uncertainty raise the risks to its forecast.
CEO Dr. Mark Gitin said the company delivered its fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of guidance. Third-quarter book-to-bill, the ratio of new orders to sales, was approximately one.
Cash pile and the Lumibird deal
Cash and cash equivalents stood at $710.7 million on September 30, up from $403.8 million at the end of 2025. Operations generated $46 million in cash during the quarter, and capital spending was $17 million.
IPG expects the Lumibird Medical purchase to close in the fourth quarter. Gitin said he anticipates it will extend the company's reach, speed growth in medical markets and add revenue in Advanced Solutions.
IPG held its earnings call at 10:00 a.m. ET on Tuesday, with Lumibird Medical's expected fourth-quarter close the next milestone.
Sources
- 8-K Filing — IPG PHOTONICS CORP (IPGP) — SEC EDGAR
- Exhibit ipgp09302026exhibit991.htm — IPG PHOTONICS CORP 8-K exhibit — SEC EDGAR
- IPG Photonics Announces Third Quarter 2026 Financial — globenewswire.com